Blaubeuren, Germany Clinical Trials

A listing of Blaubeuren, Germany clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
I am looking for
added new label for I am looking for
Advanced Filters
Found 51 clinical trials
Patients 60 Years and Older Suffering From Mandibular Fractures Registry

Approximately 200 of patients of 60 years or older who present a mandibular fracture will be enrolled in this registry. All patients will be treated and followed up according to the local standard (routine) of care at around 2 weeks, 6 weeks, 3 months and 6 months after treatment.

Bundeswehrkrankenhauses Ulm
 (9.3 away) Contact site
  • 04 Jun, 2021
  • +27 other locations
Registry for Patients With X-linked Hypophosphatemia

This is an international, multicentre, prospective, non-interventional, observational registry of patients with X-linked hypophosphatemia (XLH). The main objective of this XLH registry is to collect data to characterise the treatment, progression and long-term outcomes of XLH in both adult and paediatric settings.

Medicover Ulm MVZ
 (9.3 away) Contact site
  • 15 Mar, 2021
  • +105 other locations
Observational Study of Patients With Moderate to Severe Chronic Plaque Psoriasis

This study will assess the use of risankizumab in adult patients with moderate to severe chronic plaque psoriasis and compare risankizumab to other commonly used biologics.

Praxis fuer Innere Medizin/Rhe /ID# 213653
 (0.9 away) Contact site
  • 02 Feb, 2021
  • +286 other locations
Edoxaban in Patients With Non-valvular Atrial Fibrillation Undergoing Percutaneous Coronary Intervention

This study is designed to gain real-world clinical data on the peri- and post-procedural usage of anticoagulation and antiplatelet therapy in patients with non-valvular atrial fibrillation (NVAF) undergoing successful percutaneous coronary intervention (PCI) treated with edoxaban.

Universit tsklinikum Ulm
 (9.2 away) Contact site
  • 22 Mar, 2021
  • +65 other locations
Intersectoral Platform (S P) of the National Pandemic Cohort Network (NAPKON)

The intersectoral platform is part of the National Pandemic Cohort Network (NAPKON) and will be used to provide a comprehensive and harmonized collection of data and biomaterial for researchers from national consortia, pharmaceutical companies and for participation in international research collaborations for the purpose of studying COVID-19 disease and future …

University Hospital Ulm
 (9.2 away) Contact site
  • 07 Mar, 2021
  • +33 other locations
Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort

Enroll-HD is a longitudinal, observational, multinational study that integrates two former Huntington's disease (HD) registries-REGISTRY in Europe, and COHORT in North America and Australasia-while also expanding to include sites in Latin America. More than 20,000 participants have now enrolled into the study. With annual assessments and no end date, Enroll-HD …

University Hopsital of Ulm
 (9.2 away) Contact site
  • 20 May, 2021
  • +255 other locations
SAVR: IMPACT of Pre-existing Comorbidities on Patient Outcomes and Prosthetic Valve Performance in a Real-world Setting.

The IMPACT Registry represents a non-interventional, prospective, open-label, multicenter, international registry with a follow-up of 5 years that includes data of patients undergoing aortic valve replacement with the Edwards INSPIRIS RESILIA Aortic Valve. The IMPACT Registry will be performed in up to 25 participating sites across Germany, Austria and Switzerland. …

Universit tsklinikum Ulm
 (9.2 away) Contact site
  • 22 Feb, 2021
  • +22 other locations
MitraClip EXPAND G4 Study

This primary objective of the EXPAND G4 study is to confirm the safety and performance of the MitraClip G4 System in a post-market setting.

Universitätsklinikum Ulm
 (9.3 away) Contact site
  • 09 Apr, 2021
  • +44 other locations
Post-authorization Safety Study on the Long Term Safety of Sonidegib in Patients With Locally Advanced Cell Carcinoma

Collect real world safety data on the use of sonidegib in adult patients with laBCC. Document major safety parameters such as on treatment deaths, adverse events (AEs)/ serious adverse events (SAEs) and discontinuation secondary to AEs.

sonidegib 200 mg
Universit tsklinikum Ulm
 (9.2 away) Contact site
  • 18 Apr, 2021
  • +44 other locations
An Innovative Approach Towards Understanding and Arresting Type 1 Diabetes (INNODIA)

INNODIA is a global consortium linking 26 academic institutions, 4 industrial partners, a small to medium enterprise (SME), and 2 patient organisations, bringing their knowledge and experience together with one common goal: "To fight type 1 diabetes". ( The project, approved in November 2015 and launched in January 2016, runs …

insulin treatment
University of Ulm
 (9.3 away) Contact site
  • 27 Jan, 2021
  • +18 other locations